Saturna Capital Corp Makes New Investment in Intuitive Surgical, Inc. $ISRG

Saturna Capital Corp purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 623 shares of the medical equipment provider’s stock, valued at approximately $339,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Tobam grew its position in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. TD Capital Management LLC lifted its stake in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC bought a new stake in Intuitive Surgical in the first quarter worth $30,000. Princeton Global Asset Management LLC acquired a new position in Intuitive Surgical during the second quarter worth $30,000. Finally, Bank of Jackson Hole Trust raised its holdings in Intuitive Surgical by 70.5% during the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 31 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $546.77 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market cap of $196.00 billion, a PE ratio of 72.32, a PEG ratio of 4.94 and a beta of 1.62. The firm has a 50-day simple moving average of $485.63 and a 200 day simple moving average of $503.34.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the sale, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. The trade was a 37.81% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, October 31st. UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Argus upped their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.